User profiles for Elihu Aranday-Cortes

Elihu Aranday-Cortes

Centre for Virus Research, University of Glasgow
Verified email at glasgow.ac.uk
Cited by 3541

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

…, T Williams, J Hughes, E Aranday-Cortes… - Nature …, 2021 - nature.com
Coronavirus disease 2019 (COVID-19) was first diagnosed in Scotland on 1 March 2020.
During the first month of the outbreak, 2,641 cases of COVID-19 led to 1,832 hospital …

Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data

…, VB Sreenu, A Kohl, E Aranday-Cortes… - Genome …, 2021 - genome.cshlp.org
We have developed periscope, a tool for the detection and quantification of subgenomic
RNA (sgRNA) in SARS-CoV-2 genomic sequence data. The translation of the SARS-CoV-2 …

Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers

E Aranday-Cortes, PJ Hogarth, DA Kaveh, AO Whelan… - PloS one, 2012 - journals.plos.org
Bovine tuberculosis (bTb) remains a major and economically important disease of livestock.
Improved ante-mortem diagnostic tools would help to underpin novel control strategies. The …

Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis

S Bhuju, E Aranday-Cortes, B Villarreal-Ramos… - PLoS …, 2012 - journals.plos.org
Bovine tuberculosis (bTB) is a chronic disease of cattle caused by Mycobacterium bovis, a
member of the Mycobacterium tuberculosis complex group of bacteria. Vaccination of cattle …

Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy

…, A da Silva Filipe, E ArandayCortes… - Journal of Viral …, 2021 - Wiley Online Library
Sustained viral response (SVR) rates for direct‐acting antiviral (DAA) therapy for hepatitis C
virus (HCV) infection routinely exceed 95%. However, a small number of patients require …

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

MA Ansari, E Aranday-Cortes, CLC Ip, A da Silva Filipe… - Elife, 2019 - elifesciences.org
10.7554/eLife.42463.001 Hepatitis C virus (HCV) is a highly variable pathogen that frequently
establishes chronic infection. This genetic variability is affected by the adaptive immune …

[HTML][HTML] Amino acid substitutions in genotype 3a hepatitis C virus polymerase protein affect responses to sofosbuvir

…, S DaSilva, C Bamford, WYJ Lee, E Aranday-Cortes… - Gastroenterology, 2019 - Elsevier
Background & Aims Sofosbuvir is a frequently used pan-genotype inhibitor of hepatitis C
virus (HCV) polymerase. This drug eliminates most chronic HCV infections, and resistance-…

Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence

…, J Shepherd, T Williams, J Hughes, E Aranday-Cortes… - MedRxiv, 2020 - medrxiv.org
SARS-CoV-2, the causative agent of COVID-19, emerged in Wuhan, China in December
2019 and spread rapidly throughout the world. Understanding the introductions of this new …

Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries

…, V Sreenu, J Hughes, E Aranday-Cortes… - Journal of …, 2017 - journal-of-hepatology.eu
We read with interest ‘‘NS5A resistance-associated substitutions in patients with genotype 1
hepatitis C virus: Prevalence and effect on treatment outcome” by Zeuzem et al. in the …

Interpreting viral deep sequencing data with GLUE

JB Singer, EC Thomson, J Hughes, E Aranday-Cortes… - Viruses, 2019 - mdpi.com
Using deep sequencing technologies such as Illumina’s platform, it is possible to obtain reads
from the viral RNA population revealing the viral genome diversity within a single host. A …